Transgenomic's Q1 Revenues Slide 4 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market Tuesday that its first-quarter revenues fell 4 percent year over year due to a software problem that resulted in reduced sample processing capacity at its New Haven, Conn., lab testing facility.

The Omaha, Neb.-based firm had total revenues of $7.2 million for the three months ended March 31, compared to $7.5 million for the first quarter of 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.